# Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry

> **NCT01999946** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 217 (actual)

## Conditions studied

- Heroin Dependence
- Opioid-Related Disorders

## Interventions

- **DRUG:** Extended-Release Naltrexone

## Key facts

- **NCT ID:** NCT01999946
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-27
- **Primary completion:** 2019-05-28
- **Final completion:** 2020-12-24
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2021-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01999946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01999946, "Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01999946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*